4.6 Article

p21WAF1/CIP1 and cancer: A shifting paradigm?

期刊

BIOFACTORS
卷 35, 期 2, 页码 161-164

出版社

WILEY-BLACKWELL
DOI: 10.1002/biof.26

关键词

p21; cancer; oncogene; tumor suppressor

资金

  1. NIH [1R01CA1294414-01A1, 1R21CA134615-01]
  2. Leukemia Research Foundation

向作者/读者索取更多资源

The cyclin-dependent kinase inhibitor p21(WAF1/CIP1) is a key mediator Of p53-dependent cell cycle arrest and may play the role of a tumor suppressor in cancer. However, it has been shown that p21 may also act as an oncogene, because it inhibits apoptosis and may promote cell proliferation in some tumors. These data point out to antagonistic duality of p21, because it possesses anticancer and procancer properties at the same time. New data suggest that more and more proteins also may play contradictory roles in cancer thus challenging current paradigm of established oncogenes and tumor suppressors. (C) 2009 International Union of Biochemistry and Molecular Biology, Inc. volume 35, Number 2, March/April 2009, Pages 161-164 . E-mail: agartel@uic.edu

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据